Caparol Arabia’s innovative anti-microbial paint helps fight against Coronavirus
Caparol Arabia has successfully tested CapaCare Protect, one of its flagship and innovative paint products, to demonstrate its use in the fight against Coronavirus. The tests were conducted in the United States and proved the efficacity of the solution in curbing the spread of coronavirus and other microbes. These tests follow the successful launch of the product in the UAE market in April 2020.
The premium interior emulsion CapaCare Protect is the only paint in the region with 99.9% kill rate against Human Coronavirus and H1N1 influenzae A. The reports were tested as per American and Japanese standards in two independent ISO 17025 laboratories in USA, approved and accredited by the International Antimicrobial Council.
CapaCare Protect is manufactured in our production plant in the UAE and has already been used over the past three months on various projects including commercial, residential areas, hospitals and schools. The demand for the product is on the rise and its production is expected to further increase following the news around positive tests to combat coronavirus.
According to global real estate advisors Savills, the Middle East has seen an impressive rise in the number of construction projects over the past decade, and this number is only set to increase with close to USD two trillion worth of projects planned and in the pipeline in the region. In this context, modern methods of construction and the solutions employed will play a vital role in ensuring the sustainable development of our cities.
Caparol offers over 125 years of global experience and has been family-owned for five generations. The brand was founded in Germany with the invention of emulsion paint technology, which transformed the way people painted buildings and homes. Caparol Arabia was established in 1999 in Dubai and is part of global company DAW, which has 6,000 employees and is present in over 40 countries.
